Yvonne Hofmann is an accomplished professional in the pharmaceutical industry, currently serving as the Head of Medical Affairs for ESTEVE Pharmaceuticals GmbH in Germany since November 2021. Their expertise includes building and leading high-performing Medical Affairs teams, managing budgets across multiple therapeutic areas including CNS, Neurology, Pain Management, Cardiology, Oncology, and Antiinfectives. Prior roles at RIEMSER Pharma GmbH involved medical advising and interim leadership responsibilities, focusing on diverse therapeutic areas, and executing medical education and advisory initiatives. Yvonne's career began in research and drug safety, with significant experience in pharmacovigilance and clinical trials management at PAREXEL, and foundational research roles at reputable institutions like Karolinska Institutet and the University of Bonn. Yvonne holds a post-doctoral degree in Biotransformation and Drug Development from Karolinska Institutet, a PhD in Molecular Biology and Genetics from the University of Bonn, and a Master's degree in Biology from the University of Bonn.